# Sitagliptin and Metformin hydrochloride

NDC: 10370-317
Generic name: sitagliptin and metformin hydrochloride
Labeler / Manufacturer: Par Health USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20260724

FDA application: ANDA204144

## Active ingredients

- SITAGLIPTIN PHOSPHATE: 50 mg/1
- METFORMIN HYDROCHLORIDE: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10370-317"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10370-317
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43e3b1c9-3cbd-8dc3-e063-6394a90a10a2